866-997-4948 (US-Canada Toll Free)

Infertility Drugs And Devices Market - Global Industry Analysis, Size, Share And Forecast, 2010 - 2017

Published By :

Transparency

Published Date : 2012-10-08

Category :

Surgical Equipment

No. of Pages : 130

Product Synopsis

This report is an effort to identify factors, which will be the driving force for the infertility drugs and devices market and sub-markets in the next few years. The report provides an extensive analysis of the industry, current market trends, industry drivers and challenges for better understanding of the market structure. The report segregates the infertility drugs and devices industry in terms of products, technology and geography. We have used a combination of primary and secondary research to arrive at the market estimates, market shares and trends. We have adopted bottom up model to derive market size of the global infertility drugs and devices market and further validated numbers with the key market participants and C-level executives.  This report highlights... Read More

Table Of Content

TABLE OF CONTENTS

CHAPTER 1 PREFACE
1.1 KEY POINTS COVERED
1.2 REPORT DESCRIPTION
1.3 RESEARCH METHODOLOGY

CHAPTER 2 EXECUTIVE SUMMARY AND MARKET OVERVIEW

CHAPTER 3 INFERTILITY DRUGS AND DEVICES MARKET ANALYSIS
3.1 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET REVENUE (USD THOUSAND) AND ANNUAL GROWTH RATE, 2010 – 2017
3.1.1 COMPARATIVE ANALYSIS OF GLOBAL INFERTILITY DRUGS AND DEVICES MARKET, 2010 V/S 2017
3.1.2 GLOBAL INFERTILITY DRUGS MARKET REVENUE, 2010 – 2017
GLOBAL INFERTILITY DEVICES MARKET REVENUE, 2010 – 2017
3.2 POPULATION GROWTH TREND
3.2.1 GLOBAL MALE AND FEMALE POPULATION GROWTH TREND BY AGE GROUP
3.2.2 INFERTILITY DRUGS AND DEVICES MARKET ATTRACTIVENESS ANALYSIS BY GEOGRAPHY
3.3 CAUSES OF INFERTILITY
3.4 MARKET DYNAMICS
3.4.1 DRIVERS
3.4.1.1 Rising number of infertile people
3.4.1.2 Increasing worldwide obesity
3.4.1.3 Rising disposable incomes of the consumers
3.4.1.4 Lifestyle hazards such as rising number of smokers, stress and pollution
3.4.1.5 Adoption of babies by homosexual couples
3.4.1.6 Availability of government support for infertility abatement procedures
3.4.2 INFERTILITY DRUGS AND DEVICES MARKET DRIVER IMPACT ANALYSIS
3.4.3 RESTRAINTS
3.4.3.1 Limited insurance covers
3.4.3.2 Religious bans on artificial insemination procedures especially the Islamic bans
3.4.3.3 Risk of repeat procedures
3.4.3.4 Traditional infertility treatments such as the Chinese infertility treatments
3.4.3.5 Ban on artificial reproduction procedures in European countries especially Turkey, Germany, Italy and France
3.4.3.6 Patent expiration of infertility drugs
3.4.4 INFERTILITY DRUGS AND DEVICES MARKET RESTRAINTS IMPACT ANALYSIS
3.4.5 OPPORTUNITY
3.4.5.1 Technological advancements in the Asia Pacific region and the developmental activities in the region
3.4.5.2 Medical tourism initiatives in the developing countries
3.4.5.3 Need for more ART cycles
3.1 MARKET SHARE ANALYSIS, 2011
3.2 PORTER’S FIVE FORCES ANALYSIS FOR THE INFERTILITY DRUGS AND DEVICES MARKET
3.2.1 BARGAINING POWER OF SUPPLIERS
3.2.1 BARGAINING POWER OF BUYERS
3.2.2 THREAT OF NEW ENTRANTS
3.2.3 THREAT OF SUBSTITUTES
3.2.4 COMPETITIVE RIVALRY

CHAPTER 4 INFERTILITY DRUGS AND DEVICES MARKET SEGMENTATION
4.1 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY TYPES
4.1.1 FEMALE INFERTILITY POPULATION PREVALENCE BY TYPES
4.1.1.1 Global Infertility drugs and devices market by Endometriosis female infertility types
4.1.1.2 Global Infertility drugs and devices market by Ovarian disorder female infertility types
4.1.1.3 Global Infertility drugs and devices market by Uterine disorder female infertility types
4.1.1.4 Global Infertility drugs and devices market by Tubal disorder female infertility types
4.1.1.5 Global Infertility drugs and devices market by Hormonal disorder female infertility types
4.1.2 MALE INFERTILITY POPULATION PREVALENCE BY TYPES
4.1.2.1 Global Infertility drugs and devices market by Azoospermia male infertility types
4.1.2.2 Global Infertility drugs and devices market by Varicocele male infertility types
4.1.2.3 Global Infertility drugs and devices market by Ejaculation Disorder male infertility types
4.1.2.4 Global Infertility drugs and devices market by Erectile Dysfunction male infertility types
4.2 INFERTILITY DRUGS AND DEVICES MARKET BY TECHNOLOGY
4.2.1 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION
4.2.2 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY ASSISTED REPRODUCTIVE TECHNOLOGIES (USD THOUSAND) 
4.2.3 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY IN VITRO FERTILIZATION (USD THOUSAND) 
4.2.4 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY SURGERY (USD THOUSAND) 57

CHAPTER 5 REGION-WISE ANALYSIS
5.1 INFERTILITY DRUGS AND DEVICES MARKET BY REGION
5.1.1 EUROPE INFERTILITY DRUGS AND DEVICES MARKET
5.1.1.1 U.K
5.1.1.2 France
5.1.1.3 Germany
5.1.1.4 Italy
5.1.1.5 Spain
5.1.2 NORTH AMERICA INFERTILITY DRUGS AND DEVICES MARKET
5.1.3 NORTH AMERICA INFERTILITY DRUGS AND DEVICES MARKET
5.1.3.1 U.S
5.1.3.2 CANADA
5.1.3.3 MEXICO
5.1.4 ASIA PACIFIC INFERTILITY DRUGS AND DEVICES MARKET
5.1.5 ASIA PACIFIC INFERTILITY DRUGS AND DEVICES MARKET
5.1.5.1 Japan
5.1.5.2 India
5.1.5.3 China
5.1.6 ROW INFERTILITY DRUGS AND DEVICES MARKET
5.1.7 ROW INFERTILITY DRUGS AND DEVICES MARKET
  5.1.7.1 Brazil’s Infertility drugs and devices market

CHAPTER 6 COMPANY PROFILES
6.1 JOHNSON & JOHNSON
6.1.1 COMPANY OVERVIEW
6.1.2 FINANCIAL OVERVIEW
6.1.3 BUSINESS STRATEGIES
6.1.4 RECENT DEVELOPMENTS
6.2 MERCK
6.2.1 COMPANY OVERVIEW
6.2.2 FINANCIAL OVERVIEW
6.2.3 BUSINESS STRATEGIES
6.2.4 PRODUCT PORTFOLIO
6.2.5 RECENT DEVELOPMENT
6.3 TEVA PHARMACEUTICALS
6.3.1 COMPANY OVERVIEW
6.3.2 FINANCIAL OVERVIEW
6.3.3 BUSINESS STRATEGIES
6.3.4 PRODUCT PORTFOLIO
6.3.5 RECENT DEVELOPMENTS
6.4 ORIGIO
6.4.1 COMPANY OVERVIEW
6.4.2 FINANCIAL OVERVIEW
6.4.3 BUSINESS STRATEGIES
6.4.4 PRODUCT PORTFOLIO
6.4.5 RECENT DEVELOPMENTS
6.5 BAYER
6.5.1 COMPANY OVERVIEW
6.5.2 FINANCIAL OVERVIEW
6.5.3 BUSINESS STRATEGIES
6.5.4 PRODUCT PORTFOLIO
6.5.5 RECENT DEVELOPMENT

List of Tables

LIST OF TABLES

TABLE 1 IMPACT ANALYSIS OF DRIVERS
TABLE 2 IMPACT ANALYSIS OF RESTRAINTS
TABLE 3 GLOBAL FEMALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND ) 
TABLE 4 GLOBAL MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND ) 
TABLE 5 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND) 
TABLE 6 U.K  INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 7 U.K POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 8 U.K MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 
TABLE 9 U.K FEMALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND ) 
TABLE 10 U.K INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 
TABLE 11 U.K INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND ) 
TABLE 12 FRANCE INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 13 FRANCE POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 14 FRANCE MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 
TABLE 15 FRANCE FEMALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND ) 
TABLE 16 FRANCE INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 
TABLE 17 FRANCE INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND ) 
TABLE 18 GERMANY INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 19 GERMANY POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 20 GERMANY MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 
TABLE 21 GERMANY FEMALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND ) 
TABLE 22 GERMANY INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND 
TABLE 23 GERMANY INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND ) 
TABLE 24 ITALY INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 25 ITALY POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 26 ITALY MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 
TABLE 27 ITALY FEMALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND ) 
TABLE 28 ITALY INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 
TABLE 29 ITALY INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND ) 
TABLE 30 SPAIN INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 31 SPAIN POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 32 SPAIN MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 
TABLE 33 SPAIN FEMALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND ) 
TABLE 34 SPAIN INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 
TABLE 35 SPAIN INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND ) 
TABLE 36 U.S INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 37 U.S POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 38 U.S MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 
TABLE 39 U.S MALE INFERTILITY POPULATION TREATED, 2010 - 2017 (THOUSAND) 
TABLE 40 U.S FEMALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 
TABLE 41 U.S INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 
TABLE 42 U.S INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND) 
TABLE 43 CANADA INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 44 CANADA POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 45 CANADA MALE INFERTILITY POPULATION PREVALENCE 2010 - 2017 (THOUSAND) 
TABLE 46 CANADA FEMALE INFERTILITY POPULATION PREVALENCE, 2010 – 2017 (THOUSAND) 
TABLE 47 CANADA INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 
TABLE 48 CANADA INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND) 
TABLE 49 MEXICO INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 50 MEXICO POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 51 MEXICO MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 
TABLE 52 MEXICO FEMALE INFERTILITY POPULATION PREVALENCE AND TREATED, 2010 - 2017 (THOUSAND) 
TABLE 53 MEXICO INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 
TABLE 54 MEXICO INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND) 
TABLE 55 JAPAN  INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 56 JAPAN POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 57 JAPAN MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 
TABLE 58 JAPAN FEMALE INFERTILITY POPULATION PREVALENCE AND TREATED, 2010 - 2017 (MILLION) 
TABLE 59 JAPAN INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 
TABLE 60 JAPAN INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD MILLION) 
TABLE 61 INDIA  INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 62 INDIA POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 63 INDIA MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND
TABLE 64 INDIA FEMALE INFERTILITY POPULATION PREVALENCE AND TREATED, 2010 - 2017 (THOUSAND) 
TABLE 65 INDIA INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 
TABLE 66 INDIA INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND) 
TABLE 67 CHINA  INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 68 CHINA POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 69 CHINA MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 
TABLE 70 CHINA FEMALE INFERTILITY POPULATION PREVALENCE AND TREATED, 2010 - 2017 (THOUSAND ) 
TABLE 71 CHINA INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 
TABLE 72 CHINA INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND ) 
TABLE 73 ROW  INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 74 ROW FEMALE INFERTILITY POPULATION PREVALENCE AND TREATED, 2010 - 2017 (THOUSAND ) 
TABLE 75 ROW INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND ) 
TABLE 76 BRAZIL  INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 77 BRAZIL POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 78 BRAZIL MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 
TABLE 79 BRAZIL FEMALE INFERTILITY POPULATION PREVALENCE AND TREATED, 2010 - 2017 (THOUSAND ) 
TABLE 80 BRAZIL INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 
TABLE 81 BRAZIL INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND ) 

List of Figures

LIST OF FIGURES

FIG. 1 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET REVENUE (USD THOUSAND) AND ANNUAL GROWTH RATE, 2010 – 2017 (%) 
FIG. 2 COMPARATIVE ANALYSIS OF GLOBAL INFERTILITY DRUGS AND DEVICES MARKET SHARE, 2010 VS 2017 
FIG. 3 GLOBAL INFERTILITY DRUGS MARKET REVENUE, 2010 – 2017 (USD THOUSAND), ANNUAL GROWTH RATE, 2010 – 2017 (%) 
FIG. 4 GLOBAL POPULATION TREND, MALE AND FEMALE POPULATION TREND, 2010 – 2017 (THOUSANDS) 
FIG. 5 GLOBAL FERTILE MALE AND FEMALE POPULATION TREND, 2010 – 2017 (THOUSANDS) 
FIG. 6 GLOBAL INFERTILITY DEVICES MARKET REVENUE, 2010 – 2017 (USD THOUSAND), ANNUAL GROWTH RATE, 2010 – 2017 (%) 
FIG. 7 MARKET ATTRACTIVENESS - INFERTILITY DRUGS AND DEVICES MARKET BY GEOGRAPHY 
FIG. 8 CAUSES OF INFERTILITY 
FIG. 9 PORTER’S FIVE FORCES ANALYSIS FOR THE INFERTILITY DRUGS AND DEVICES MARKET 
FIG. 10 COMPARITIVE ANALYSIS OF INFERTILITY DRUGS AND DEVICES MARKET SHARE BY GEOGRAPHY, 2010 AND 2017 (%) 
FIG. 11 EUROPE INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND), ANNUAL GROWTH RATE, 2010 – 2017 (%) 
FIG. 12 NORTH AMERICA INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND), ANNUAL GROWTH RATE, 2010 – 2017 (%) 
FIG. 13 ASIA PACIFIC INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND), ANNUAL GROWTH RATE, 2010 – 2017 (%) 
FIG. 14 DECLINING FERTILITY RATE IN JAPAN, 2007 - 2011 
FIG. 15 ROW INFERTILITY INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND), ANNUAL GROWTH RATE, 2010 – 2017 (%) 
FIG. 16 JOHNSON & JOHNSON’S ANNUAL SALES, 2007 – 2011 (USD MILLION), ANNUAL GROWTH RATE, 2007 – 2010 (%) 
FIG. 17 MERCK’S ANNUAL REVENUE, 2007 – 2011 (USD MILLION), ANNUAL GROWTH RATE, 2007 - 2010 (%) 
FIG. 18 TEVA PHARMACEUTICAL’S ANNUAL REVENUE, 2007 – 2011 (USD MILLION), ANNUAL GROWTH RATE, 2007 - 2010 (%) 
FIG. 19 ORIGIO’S ANNUAL REVENUE, 2010 – 2011 (USD MILLION) 
FIG. 20 BAYER’S ANNUAL SALES, 2010 – 2011 (USD MILLION) 

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *

Upcoming Reports

  • Autopilot Systems Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2014 - 2020

    By - Transparency

    Autopilot system is an integral part of flight management system. It is utilized to control a vehicle without constant monitoring by a human operator. This system do not replaces a human operator instead assist them in operating a vehicle. They are widely used in aviations, missiles, spacecrafts and ships among others. An autopilot system consists of three components including programmer or mode selector, computer and actuator. A programmer or mode selector allows the pilot to program the autopilot system to achieve intended flight profile and helps in interacting with avionic system such...

  • Water Trading Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

    By - Transparency

    Water trading is a voluntary transfer of certain quantity of water between the buyer and the seller, so that the buyer of water can satisfy the demand at its end. It is a solution for all the verticals of end users that need water. Therefore, water trading serves as a solution for different users such as urban and agricultural that provides equal price and allocates water according to the demand. As quoted by the Forbes, there are many projects which have done hundreds of transactions of water worth USD 10 trillion across the globe. It has also identified several water...

  • Greece: wheat market

    By - Williams and Marshal Strategy

    the report presents an elaborate overview of the main market participants, the price fluctuations, the growth and demand drivers of the market and the factors, influencing its development. Last but not least, the report presents a general overview of the economy of Greece in 2008-2012 and a forecast for its development in the medium term. The report on the wheat market in Greece includes: Analysis and dynamics of the economy of Greece; Forecast for the development of the economy of Greece; Analysis and forecast of market volume and dynamics; Volume, dynamics and analysis of domestic...